R1 RCM is a provider of revenue cycle management (RCM) services to healthcare providers, including health systems and hospitals, physicians groups, and municipal and private emergency medical service (EMS) providers. The company manages healthcare providers' revenue cycle operations, which encompass processes including patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation and collections from patients and payers. The company's primary service offering consists of end-to-end RCM services for health systems, hospitals, physician groups, and EMS providers, which the company deploys through an operating partner relationship or a co-managed relationship.

Agnico-Eagle Mines is a gold mining company with mining operations in Canada, Mexico and Finland. Co. earns a proportion of its revenues from the production and sale of gold in both dore bar and concentrate form. The remainder of revenue and cash flow is generated by the production and sale of byproduct metals. The revenue from byproduct metals is mainly generated by production at the LaRonde mine in Canada (silver, zinc, copper and lead) and the Pinos Altos mine in Mexico (silver).

Air Transport Services Group is a holding company. Through its subsidiaries, the company owns and leases aircraft to external customers and its airline subsidiaries. The company's services include: Aircraft Leasing, which owns and leases aircraft through its subsidiary Cargo Aircraft Management, Inc.; Airline Operations, which provides various combinations of aircraft, crews, maintenance and insurance to provide customized transportation capacity through its subsidiaries, ABX Air, Inc., Air Transport International, Inc. and Omni Air International, LLC; and Support Services, which provides air transportation related services including aircraft maintenance and modification, ground handling and crew training.

Akero Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious metabolic diseases. The company's initial focus is on nonalcoholic steatohepatitis ("NASH"), a disease without any approved therapies. NASH is a severe form of nonalcoholic fatty liver disease ("NAFLD"), characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, failure, cancer of the liver, and death. The company is developing AKR-001, an analog of fibroblast growth factor 21 ("FGF21"), for NASH and plan to initiate a Phase 2a clinical trial for AKR-001 in NASH patients with fibrosis in the middle of 2019.

Allakos is a clinical stage biotechnology company. The company is developing AK002, its wholly owned monoclonal antibody, for the treatment of eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic esophagitis and mast cell related diseases. AK002 selectively targets both eosinophils and mast cells, white blood cells that are distributed in the body and play a primary role in the inflammatory response. Inappropriately activated eosinophils and mast cells have been identified as key drivers in a number of severe diseases affecting the gastrointestinal tract, eyes, skin, lungs and other organs. As such, AK002 has the potential to treat a number of severe diseases.

Allison Transmission Holdings is a holding company. Through its subsidiaries, the company manufactures fully-automatic transmissions for medium- and heavy-duty commercial vehicles and medium- and heavy-tactical U.S. defense vehicles. The company's transmissions are in used various applications, including on-highway trucks (distribution, refuse, construction, fire and emergency), buses (mainly school, transit and electric hybrid-transit), motorhomes, off-highway vehicles and equipment (mainly energy, mining and construction) and defense vehicles (wheeled and tracked). The company also sells replacement parts, support equipment and other products to service the installed base of vehicles utilizing its transmissions.

Amedisys is a healthcare services company focused on providing care in the home. The company's operations involve servicing patients across the United States through its operating divisions: home health, hospice and personal care. The company's Home Health segment provides healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. Hospice care is designed to provide comfort and support for those who are dealing with a terminal illness such as heart disease, pulmonary disease, Alzheimer's or cancer. Personal care provides assistance with the activities of daily living.

American Woodmark manufactures and distributes kitchen, bath and home organization products for the remodeling and new home construction markets. The company provides a variety of products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization and hardware. The company's cabinetry products are available in a variety of designs, finishes and finish colors and door styles. The company provides products in the following categories: made-to-order, which are special ordered and shipped directly to the home from the factory; and stock, which represents cash and carry products sold through home centers. The company's home organization products are stock products.

Avanos Medical is a medical technology company focused on delivering medical device products with manufacturing facilities in the United States, Mexico, France, Germany and Tunisia. The company provides a portfolio of product offerings focused on chronic care and pain management. Chronic Care product includes: digestive health products such as Mic-Key enteral feeding tubes, and Corpak patient feeding solutions; and respiratory health products such as closed airway suction systems. Pain Management product includes: acute pain products such as On-Q and ambIT surgical pain pumps; and interventional pain solutions, which provides minimally invasive pain relieving therapies.

Compass Minerals International is a holding company. Through its wholly owned subsidiaries, the company is a provider of minerals, including salt, secondary nutrients and micronutrients, and specialty chemicals. The company has three reportable segments: Salt, which produces, markets and sells salt and magnesium chloride and sodium chloride; Plant Nutrition North America, which includes sales of sulfate of potash specialty fertilizer and specialty plant nutrients; and Plant Nutrition South America, which manufactures, distributes and markets an array of specialty plant nutrients and supplements developed and formulated from primary and secondary nutrients, specialty plant nutrients and biostimulants.

Douglas Dynamics is a manufacturer and upfitter of commercial work truck attachments and equipment. The company's segments are: Work Truck Attachments, which includes manufactured snow and ice control attachments sold under the FISHER?, HENDERSON?, SNOWEX? and WESTERN? brands; and Work Truck Solutions, which includes the upfit of attachments and storage solutions for commercial work vehicles under the DEJANA? brand and its related sub-brands. The company's Work Truck Solutions products consist of truck and vehicle upfits where the company attaches component pieces of equipment, truck bodies, racking, and storage solutions to a vehicle chassis, and which are typically used by end-users for work related purposes.

Encompass Health is a provider of healthcare services, providing both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. The company's inpatient rehabilitation hospitals provide specialized rehabilitative care across an array of diagnoses and deliver patient care services. The company's home health agencies provide home care services such as skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The company also provides hospice services such as pain control and symptom management, and emotional and spiritual support to terminally ill patients and their families.

Fiserv is a provider of financial services technology. The company provides account processing systems, electronic payments processing products and services, internet and mobile banking systems, and related services. The company's segments are: First Data, which provides merchant acquiring, e-commerce, mobile commerce, and other business solutions; Payments and Industry Products, which provides electronic bill payment and presentment services, internet and mobile banking software; and Financial Institution Services, which provides financial institutions with account processing services, item processing and source capture services, loan origination and servicing products, and cash management, among others.

FleetCor Technologies is provider of commercial payment solutions. The company's five primary product lines are Fuel, which provides fuel payment solutions to businesses and government entities who operate vehicle fleets, as well as to main oil companies;Lodging, which provides lodging payment solutions to employees who travel overnight for work purposes; Tolls, which provides an electronic toll and parking payments product; Corporate Payments, which include virtual cards, purchasing cards, travel and entertainment cards; and Gift, which provides gift card product management and processing services. Additionally, the company provides other payment products including fleet maintenance and employee benefits.

FMC is an agricultural sciences company. The company provides solutions to growers around the world with a product portfolio fueled by a discovery and development pipeline in crop protection, plant health, and personnel pest and turf management. This combination of technologies includes insect control products based on Rynaxypyr? and Cyazypyr? active ingredients; Authority?, Boral?, Centium?, Command? and Gamit? branded herbicides; Talstar? and Hero? insecticides; and flutriafol-based fungicides. The company's products are used in agriculture to improve crop yield and quality by controlling a range of insects, weeds and disease, as well as in non-agricultural markets for pest control.

Global Payments is a pure play payment technology company providing payments and software solutions to merchants and financial institutions. The company has three segments: Merchant Solutions, which includes authorization services, chargeback resolution, and payment security services; Issuer Solutions, which provides solutions that enable financial institutions and other financial service providers to manage their card portfolios and reduces technical difficulty and overhead on a single platform; and Business and Consumer Solutions, which provides general purpose reloadable prepaid debit and payroll cards, demand deposit accounts and other financial service solutions through its Netspend? brand.

Huron Consulting Group is a consulting firm. The company partners with clients to develop strategies and implement solutions that enable the transformative change its clients need. The company's segments are: Healthcare, which provides care transformation, financial and operational, technology and analytics, and leadership development; Business Advisory, which provides services to large and middle market organizations, not-for-profit organizations, lending institutions, law firms, investment banks and private equity firms; and Education, which provides consulting and technology solutions to higher education institutions and academic medical centers.

Innospec develops, manufactures, blends, markets and supplies chemicals for use as fuel additives, and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The company has four segments: Fuel Specialties, which develops, manufactures, blends, markets and supplies a range of chemical products; Performance Chemicals, which provides products focused on the personal care, home care, agrochemical and mining markets; Oilfield Services, which develops and markets products to prevent loss of mud in drilling operations, and chemical solutions; and Octane Additives, which comprises sales of tetra ethyl lead for use in automotive gasoline.

Kaman conducts business in the aerospace, medical and industrial markets. The company produces and markets proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft; and safe and arming solutions for missile and bomb systems for the United States and allied militaries. The company also manufactures and supports its K-MAX? manned and unmanned medium-to-heavy lift helicopters and restores, modifies and supports its SH-2G Super Seasprite maritime helicopters. The company has one business segment, Aerospace.

Kronos Worldwide is a producer and marketer of titanium dioxide pigments (TiO2), a base industrial product used in a range of applications. The company, along with its distributors and agents, sells and provides technical services for customers in countries in Europe, North America and Asia Pacific. The company operates two ilmenite mines in Norway pursuant to a governmental concession with an unlimited term. The company also manufactures and sells iron-based chemicals, which are co-products and processed co-products of the sulfate and chloride process TiO2 pigment production. The company manufactures and sells titanium oxychloride and titanyl sulfate, which are side-stream products from the production of TiO2.

Kura Oncology is a clinical-stage biopharmaceutical company engaged in developing medicines for the treatment of cancer. The company's key product candidate, tipifarnib, is a selective and orally bioavailable inhibitor of farnesyl transferase. The company's second product candidate is KO-947, a selective small molecule inhibitor of extracellular signal related kinase, which the company is developing as a potential treatment for patients with tumors that have dysregulated activity due to mutations or other mechanisms in the mitogen-activated protein kinase pathway. The company's third product candidate is KO-539, a selective small molecule inhibitor of the menin-mixed lineage leukemia, protein-protein interaction.

Las Vegas Sands is a developer of destination properties (Integrated Resorts) that feature accommodations, gaming, entertainment and retail malls, convention and exhibition facilities, restaurants and other amenities. The company owns and operates Integrated Resorts in Asia and the United States. Through its ownership of Sands China Ltd., the company owns and operates properties including The Venetian Macao Resort Hotel, Sands Cotai Central, The Parisian Macao, The Plaza Macao and Four Seasons Hotel Macao, Cotai Strip, and the Sands Macao. In Singapore, the company owns and operates the Marina Bay Sands. The company's Las Vegas Operating Properties includes The Venetian Resort Las Vegas and the Sands Expo Center.

La-Z-Boy manufactures, markets, imports, exports, distributes and retails upholstery furniture products. In addition, the company imports, distributes and retails accessories and casegoods (wood) furniture products. The company's reportable operating segments are: Upholstery, which manufactures and imports upholstered furniture such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, ottomans and sleeper sofas; Casegoods, which imports, markets, and distributes casegoods (wood) furniture as well as manufactures some custom upholstered furniture; and Retail, which sells upholstered furniture, in addition to some casegoods and other accessories.

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases. The company's main product candidate, MGL-3196 (resmetirom), is a proprietary, orally administered, small molecule, liver-directed, thyroid hormone receptor-? selective agonist being developed as a once-daily oral pill that can potentially be used to treat a number of disease states including non-alcoholic steatohepatitis.

Methanex is a producer and supplier of methanol to the international markets of Asia Pacific, North America, Europe and South America. Co.'s operations consist of the production and sale of methanol, a commodity chemical.

Penn National Gaming is an owner and manager of gaming and racing facilities and video gaming terminal operations with a focus on slot machine entertainment. In addition, the company operates an interactive gaming division through its subsidiary, Penn Interactive Ventures, LLC. The company's segment's properties include Ameristar East Chicago, Hollywood Casino Bangor, 1st Jackpot Casino, Ameristar Vicksburg, Boomtown Biloxi, Boomtown Bossier City, Ameristar Black Hawk, Cactus Petes and Horseshu, Ameristar Council Bluffs, Argosy Casino Alton, Argosy Casino Riverside, Freehold Raceway, Retama Park Racetrack, Sam Houston Race Park and Valley Race Park, and Sanford-Orlando Kennel Club, among others.

Tutor Perini is a construction company. The company operates in three segments: Civil, which focuses on public works construction and the replacement and reconstruction of infrastructure; Building, which provides services to various building markets for private and public works customers, including hospitality and gaming, transportation, health care, commercial offices, sports and entertainment, education, correctional facilities, biotech and pharmaceutical, among others; and Specialty Contractors, which focuses on electrical, mechanical, plumbing, heating, ventilation and air conditioning, fire protection systems and pneumatically placed concrete for civil and building construction projects.

Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat diseases with unmet medical needs. The company is developing a suite of clinical-stage drug candidates from its proprietary XmAb? technology platforms that are designed to treat cancer and autoimmune diseases. The company's protein engineering knowledge and the XmAb technologies are focused on the parts of the antibody that interacts with various segments of the immune system and controls antibody structure. This segment, referred to as the Fc domain, is constant and interchangeable among antibodies.